The Future is Robotic Surgery. These Students Get a Front-Row Seat
UCSF offers unique opportunities for medical students to gain certification to assist in robotic surgery as part of extensive robotic surgery curriculum.
UCSF Health Top Rated for Overall Quality for Third Year in a Row
For the third year in a row, UCSF Medical Center has earned a five-star rating for overall hospital quality from the Centers for Medicare & Medicaid Services (CMS).
New Approach for Smarter, Safer Cancer Treatment
UCSF researchers studied personalized chemotherapy conditioning for children to maximize chemotherapy exposure for each child versus the current generalized dosage based on weight and age. Their approach reveals higher survival and lower recurrence rates.
What Causes Shoulder Osteoarthritis? This Study Hopes to Find Out
The American Orthopaedic Society for Sports Medicine (AOSSM) and the Arthritis Foundation have awarded a $500,000 multicenter research grant to UCSF Health’s Michael Davies, MD, and co-principal investigators Brian Feeley, MD, of UCSF, and Robert Tashjian, MD, of the University of Utah, for a first-of-its-kind collaboration intended to advance research and treatment of osteoarthritis.
This Protein Slows the Aging Brain, and We Know How to Counter It
Scientists discover a protein that gets concentrated in the brain during aging, leading brain connections to wither and cognitive decline to accelerate - and a way to counter its effects.
From Chronic Pain to Parkinson’s, 4 Ways DBS is Changing Care
UCSF looks back on four ways it pioneered deep brain stimulation with the help of federal funding, helping patients with Parkinson’s Disease, chronic pain, depression, and more.
Some Breast Tumors Tunnel Into Fat to Fuel Up. Can We Stop Them?
A UCSF team discover how breast cancer tumors tunnel into neighboring fat cells to trigger fat breakdown in order to feed on fat and grow.
Two UCSF Researchers Are Named Pew Latin American Fellows
Two new Pew Latin American fellows, Beatriz De Moraes, PhD, and Lilian Gomes de Oliveira, PhD, will each receive a $30,000 annual stipend for two years to support their work at the crossroads of immunology and neuroscience.
New Device Reduces Heart Failure Symptoms
The vascular surgery team at UCSF Health recently became the first among University of California medical centers to implant a Barostim device to treat heart failure. The team implanted the device in a young woman with the goal of reducing her heart failure symptoms and improving her quality of life.
Barostim is a new, FDA-approved, implantable device that rebalances the autonomic nervous system, with the goal of improving outcomes for heart failure patients with reduced ejection fraction.